greeksoup/ stock research

Omega Healthcare Investors (OHI) FY2024 results: revenue $1.1 billion, up 10.7% on the year

Omega Healthcare Investors Inc. (OHI) reported revenue of $1.1 billion for fiscal 2024, the year ended 31 December 2024, up 10.7% on the year before. Net income was $406 million, up 67.8%, and diluted earnings per share $1.55. The figures are the company's own, from the 10-K it filed with the SEC on 13 February 2025.

Revenue
$1.1 billion
+10.7% on the year
FY2017FY2024
Operating margin
38.3%
16.4% a year earlier
FY2017FY2024
Net income
$406 million
+67.8% on the year
FY2017FY2024
Diluted EPS
$1.55
+55.0% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue1,051950878+10.7%
Operating income40315678.6+157.7%
Operating margin38.3%16.4%8.9%
Interest expense222236233-5.9%
Pre-tax income429255436+68.1%
Income tax10.96.34.6+73.6%
Effective tax rate2.5%2.5%1.0%
Net income406242427+67.8%
Net margin38.6%25.5%48.6%
Diluted EPS$1.55$1.00$1.80+55.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow749618626+21.3%
Capital expenditure37.838.047.2-0.7%
Free cash flow712580579+22.8%
Free cash flow margin67.7%61.0%65.9%
Cash from investing-671-0.8443
Cash from financing26.3-473-789
Depreciation and amortisation305320332-4.7%
Share-based compensation36.735.127.3+4.6%
Buybacksn/an/a142
Dividends paid685644633+6.5%
Dividend per share$2.68$2.68$2.680.0%
Diluted shares, weighted270m250m244m+8.0%
Shares outstanding at period end279m245m234m+13.8%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity4,5373,5753,609+26.9%
Non-controlling interest194188194+3.4%
Debt4,8395,0675,287-4.5%
Other liabilities328288315+14.0%
Total liabilities and equity9,8989,1179,405+8.6%
Goodwill644644643-0.0%
Intangible assets28.10.71.4+4,015.0%
Loans1,4281,2121,043+17.8%
Cash and equivalents518443297+17.1%
Other assets7,2806,8187,421+6.8%
Total assets9,8989,1179,405+8.6%

10-K for the year ended 31 December 2024, filed 13 February 2025: the filing.